Sprout Health vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Willow beats Sprout Health overall, scoring 7.5/10 vs 5.8/10. Sprout Health is more affordable at $199/mo vs $299/mo. Choose Sprout Health for users who want a dedicated care coordinator and locked titra. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Sprout Health and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Sprout Health

#49 of 52

5.8/10

Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.

Visit Sprout Health

Higher Rated

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Sprout Health	Willow
Our Score	5.8/10	7.5/10
Starting Price	$199/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#49	#24
Get started	Visit Sprout Health	Visit Willow

Pros & Cons Compared

Sprout Health

Pros

+Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
+Dedicated care coordinator assigned to each patient, not a rotating pool of providers
+Transparent pricing: $250/mo covers medication, shipping, and all consultations
+Operating since 2022 with a consistent track record, no sudden pricing changes or service disruptions

Cons

−$250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes
−No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Sprout Health with a score of 7.5/10 vs 5.8/10. If budget is your priority, Sprout Health starts at $199/mo compared to Willow's $299/mo. Sprout Health offers both brand-name and compounded medications, giving you more flexibility. Choose Sprout Health if you want: users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Sprout Health nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review